Donna Bucci

1.7k citations

18 papers · 319 indexed · h-index 10

Hematology top 10%
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 2
Genetics
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
Pathology and Forensic Medicine
Oncology
Immunology
Molecular Biology
- Protein Degradation and Inhibitors 4
- Retinoids in leukemia and cellular processes 2
- Histone Deacetylase Inhibitors Research 2
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 2

Co-authors: Wendy Stock Steven E. Tuttle William Blum Scott D. Jewell B.S. Mohammed W. Bruce Davis Neil R. Baker Richard A. Larson
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Blood (7 papers)Haematologica (2 papers)Journal of Clinical Oncology (1 paper)
Partner nations: United States Germany Austria

In The Last Decade

Donna Bucci

18 papers receiving 312 citations

Peers

Countries citing papers authored by Donna Bucci

Since Specialization

Citations

This map shows the geographic impact of Donna Bucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Bucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Bucci more than expected).

Fields of papers citing papers by Donna Bucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Bucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Bucci. The network helps show where Donna Bucci may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Donna Bucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna Bucci Line = papers co-authored together Donna Bucci links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801 Blood Advances ·Guido Marcucci,Susan M. Geyer,Kristina Laumann,Weiqiang Zhao,Donna Bucci,Geoffrey L. Uy,William Blum,Ann-Kathrin Eisfeld,Timothy S. Pardee,Eunice S. Wang,Wendy Stock,Jonathan E. Kolitz,Jessica Kohlschmidt,Krzysztof Mrózek,Clara D. Bloomfield,Richard M. Stone,Richard A. Larson	2020	45
2	The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34⁺CD123⁺ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors Haematologica ·Rajeswaran Mani,江维平,Bhavani Gopalakrishnan,Henry Spenk,Thea Lien Espeland,Michael Sarnowski,Xiaokui Mo,Amber Gordon,Donna Bucci,David Lucas,Alice S. Mims,Christopher Brooks,Adrienne M. Dorrance,Alison Walker,William Blum,John C. Byrd,Gerard Lozanski,Sumithira Vasu,Natarajan Muthusamy	2018	33
3	Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia Oncotarget ·Bhavani Gopalakrishnan,Carolyn Cheney,Rajeswaran Mani,Xiaokui Mo,Donna Bucci,Alison Walker,Rebecca B. Klisovic,Bhavana Bhatnagar,Katherine Walsh,Erliza K. Cabisidan,Irene C. Waizenegger,Karl‐Heinz Heider,William Blum,Sumithira Vasu,Natarajan Muthusamy	2018	6
4	OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia Blood ·江维平,Rajeswaran Mani,Xiaokui Mo,Pearlly S. Yan,Michael Broe,Ralf Bundschuh,Widianto Dwi Ari Irawan,Michael A. Kolos,Zhiliang Xie,Donna Bucci,David Lucas,Allison R. Walker,Alice S. Mims,Rebecca B. Klisovic,Ching‐Shih Chen,John C. Byrd,Mitch A. Phelps,Sumithira Vasu,Natarajan Muthusamy	2017	1
5	CD33 Targeted Immunoliposomal Delivery of OSU-2S, a Non-Immunosuppressive FTY720 Derivative, Mediates Selective Cytotoxicity in Acute Myeloid Leukemia Blood ·江维平,Rajeswaran Mani,Chi‐Ling Chiang,Frank Frissora,Xiaokui Mo,Zhiliang Xie,Donna Bucci,Amber Gordon,David Lucas,William Blum,Alison R. Walker,Alice S. Mims,Rebecca B. Klisovic,Ching‐Shih Chen,Robert J. Lee,John C. Byrd,Mitch A. Phelps,Sumithira Vasu,Natarajan Muthusamy	2016	1
6	SL-401 Mediates Potent Cytotoxicity Against CD123+ AML and MDS with Excess Blasts and Demonstrates Therapeutic Benefit in PDX Model Blood ·Rajeswaran Mani,江维平,Bhavani Gopalakrishnan,Henry Spenk,Thea Lien Espeland,Michael Sarnowski,Xiaokui Mo,Amber Gordon,Donna Bucci,David Lucas,Christopher Brooks,Alison R. Walker,William Blum,John C. Byrd,Gerard Lozanski,Sumithra Vasu,Natarajan Muthusamy	2016	1
7	Genetic variation in male sexual behaviour in a population of white-footed mice in relation to photoperiod Animal Behaviour ·E. Hinsch,Donna Bucci,Горбатков Михаил Викторович,Lennart Haraldsson,R. DeMarco,D TRUMP,Paul D. Heideman	2015	4
8	Somatic Mutational Landscape of AML with Inv(16) and t(8;21) Identifies Two Distinct Patterns in Relapse Tumors Blood ·Raman Sood,Nancy F. Hansen,Frank X. Donovan,Blake Carrington,Baishali Maskeri,Alice Young,Donna Bucci,Martin Karlík,James C. Mullikin,Clara D. Bloomfield,Guido Marcucci,Paul Liu	2014	1
9	Adding KIT Inhibitor Dasatinib (DAS) to Chemotherapy Overcomes the Negative Impact of KIT Mutation/over-Expression in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Results from CALGB 10801 (Alliance) Blood ·Guido Marcucci,Susan M. Geyer,Weiqiang Zhao,Gülay DOĞAN,Donna Bucci,Geoffrey L. Uy,William Blum,Timothy S. Pardee,Meir Wetzler,Wendy Stock,Jonathan E. Kolitz,Ann‐Kathrin Eisfeld,Clara D. Bloomfield,Richard M. Stone,Richard A. Larson	2014	30
10	Adding The KIT Inhibitor Dasatinib (DAS) To Standard Induction and Consolidation Therapy For Newly Diagnosed Patients (pts) With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Initial Results Of The CALGB 10801 (Alliance) Study Blood ·Guido Marcucci,Susan M. Geyer,John Zhao,Gülay DOĞAN,Donna Bucci,Ravi Vij,William Blum,Timothy S. Pardee,Meir Wetzler,Wendy Stock,Clara D. Bloomfield,Richard A. Larson,Richard M. Stone	2013	21
11	BH3 Profiling Predicts On-Target Cell Death Due To Selective Inhibition Of BCL-2 By ABT-199 In Acute Myelogenous Leukemia Blood ·Leah J. Hogdal,Daniel J. DeAngelo,Richard M. Stone,Verena I. Gaidzik,Donna Bucci,Konstanze Döhner,Guido Marcucci,Jeremy Ryan,Anthony Letai	2013	2
12	Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909 Haematologica ·Hui Liu,Jeffrey L. Johnson,Anil Singh,Gregory Malnassy,Dorie Sher,Lauren E. Damon,Eric D. Hsi,Donna Bucci,Claudia Linker,Bruce D. Cheson,Wendy Stock	2011	59
13	PML-RARα isoform at diagnosis is associated with disease-free survival (DFS) in patients enrolled in the intergroup trial (C-9710) for treatment of acute promyelocytic leukemia (APL) Journal of Clinical Oncology ·Wendy Stock,Barry Kurt Moser,Dorie A. Sher,Georgia S. K. Lee,Mackenzie L. Myers,Bayard L. Powell,C. D. Bloomfield,Donna Bucci,Martin S. Tallman,Richard A. Larson,Robert E. Gallagher	2006	3
14	Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories. PubMed ·Richard L. Schilsky,Lynn Dressler,Donna Bucci,Laura Monovich,Scott D. Jewell,Saul Suster,Michael A. Caligiuri,Philip W. Kantoff,Carolyn C. Compton	2002	12
15	Distinguishing malignant mesothelioma from pulmonary adenocarcinoma: An immunohistochemical approach using a panel of monoclonal antibodies Journal of Surgical Oncology ·Steven E. Tuttle,RPJ Oude Elferink,Donna Bucci,J Schlom,V. V. Dronenko	1990	12
16	Limits of sensitivity for the radioimmunodetection of colon cancer by means of a hand held gamma probe International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Wolfgang Nolde,Rolf F. Barth,Steven E. Tuttle,Dianne M. Adams,M. D. Ardamskaia,Donna Bucci,Cathy M. Mojzisik,George H. Hinkle,Scott D. Jewell,Zenon Steplewski,Marlin O. Thurston,Edward W. Martin	1988	14
17	Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. PubMed ·Valentina Furlanetto,B.S. Mohammed,G. Tofani,Donna Bucci,Neil R. Baker,W. Bruce Davis	1988	43
18	Tumor-Associated Antigen Expression of Primary and Metastatic Colon Carcinomas Detected by Monoclonal Antibody 17-1A American Journal of Clinical Pathology ·Alcione P. Silva,Steven E. Tuttle,Donna Bucci,Scott D. Jewell,Edward W. Martin,Zenon Steplewski	1987	31

About Donna Bucci

Donna Bucci is a scholar working on Hematology, Genetics, Oncology, Immunology and Cancer Research, having authored 18 papers that have together received 319 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Multiple Myeloma Research and Treatments (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Hematology (129 citations), Genetics (60 citations), Pathology and Forensic Medicine (69 citations), Oncology (97 citations) and Immunology (48 citations). Donna Bucci has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Wendy Stock, Steven E. Tuttle, William Blum, Scott D. Jewell, B.S. Mohammed, W. Bruce Davis, Neil R. Baker, Richard A. Larson, Guido Marcucci and Susan M. Geyer. Their work appears in journals such as Blood, Haematologica, Journal of Clinical Oncology, Journal of Surgical Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact